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Aim of study
Despite advances in screening procedures and the use of
adjuvant therapy, approximately 50% of patients with
colorectal cancer will develop metastatic disease. Surgical
resection is now well accepted as the standard treatment
for the liver metastases from colorectal cancer but tumour
ablative techniques have been developed in recent years.
The goal is to use them in patients with hepatic metas-
tases, which are not totally resectable.
Aim of this study was to evaluate the role of radiofre-
quency ablation in the treatment of the hepatic metastasis
of colorectal cancer (CRC).
Materials and methods
From November 2005 to July 2007 49 radiofrequency
ablations have been performed in 19 patients (11 male
and 8 female; mean age 65 years: range 50–78 years). The
disease-free period was between 5 and 32 months.
Hepatic nodules had a diameter inferior to 3 cm in 4
cases, while in 3 cases a single lesion was present. One
patient had a single lesion after 2 courses of intravenous
systemic chemotherapy, which had a reduced greater
lesion (from 6 to 3 cm) while a 2 cm lesion had disap-
peared. In the remaining 12 patients the mean number of
lesions is 3 (range 1–13) with a diameter between 3 and
12 cm. The radiofrequency ablation has been performed
during laparotomy and vascular exclusion through clam-
page of the liver hilum in 4 cases and percutaneously
under ultrasound guide in the remaining 15 cases.
All patients underwent follow up by CT scan, CEA level
and ultrasound every 3 months.
Results
One patient only has completed a 4 year follow up and is
alive without local recurrence but with a cerebral metasta-
sis. The other 18 patients have a 32 months follow-up
with a survival of 50% (9 on 18).
Conclusion
Percutaneous, image guided, tumour ablation with ther-
mal energy source, microwaves or laser has received
increasing attention permitting the destruction of
tumours without necessitating their removal and in many
cases can be used in place of invasive and expensive tech-
niques.
Radiofrequency current, converted into heat through ion
agitation and friction, can destroy liver tumours by means
of coagulation necrosis.
In clinical grounds RF ablation has been used for the treat-
ment of different neoplasms including osteoid osteoma,
hepatocellular carcinoma, renal cells carcinoma, hyper-
functioning adenoma and hepatic, cerebral and retroperi-
toneal metastases from several primary tumours.
In conclusion in our experience the radiofrequency abla-
tion is a valid alternative method in the treatment of the
hepatic metastasis of colorectal cancer.
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